Shigeo Morimoto

1.9k total citations
62 papers, 1.5k citations indexed

About

Shigeo Morimoto is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Shigeo Morimoto has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Organic Chemistry and 16 papers in Epidemiology. Recurrent topics in Shigeo Morimoto's work include Cancer therapeutics and mechanisms (15 papers), Carbohydrate Chemistry and Synthesis (10 papers) and Pneumonia and Respiratory Infections (7 papers). Shigeo Morimoto is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), Carbohydrate Chemistry and Synthesis (10 papers) and Pneumonia and Respiratory Infections (7 papers). Shigeo Morimoto collaborates with scholars based in Japan, United States and Belarus. Shigeo Morimoto's co-authors include Yoshiaki Watanabe, SADAFUMI OMURA, Takashi Adachi, Yōko Takahashi, Toshi Komurasaki, Hitoshi Toyoda, Toshifumi Asaka, Daisuke Uchida, Tatsuhiko Urakami and Kazunori Hanada and has published in prestigious journals such as PLoS ONE, Diabetes Care and Oncogene.

In The Last Decade

Shigeo Morimoto

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeo Morimoto Japan 23 638 348 305 209 173 62 1.5k
Yuzuru Akamatsu Japan 25 1.4k 2.2× 311 0.9× 327 1.1× 281 1.3× 216 1.2× 90 2.5k
Sujata Sharma India 26 1.2k 1.8× 177 0.5× 137 0.4× 144 0.7× 174 1.0× 100 2.1k
Teck Kwang Lim Singapore 28 1.2k 1.9× 176 0.5× 292 1.0× 113 0.5× 216 1.2× 78 2.5k
Nicola G. Wallis United Kingdom 23 908 1.4× 317 0.9× 196 0.6× 161 0.8× 198 1.1× 45 1.8k
Pei‐Lan He China 26 697 1.1× 225 0.6× 312 1.0× 174 0.8× 189 1.1× 40 2.1k
K. Vosbeck Switzerland 18 608 1.0× 264 0.8× 120 0.4× 104 0.5× 91 0.5× 36 1.3k
Sanjay Kumar India 22 704 1.1× 242 0.7× 107 0.4× 117 0.6× 77 0.4× 70 1.8k
William E. Alborn United States 23 882 1.4× 142 0.4× 217 0.7× 250 1.2× 365 2.1× 35 2.1k
Ajith V. Kamath United States 18 1.3k 2.0× 129 0.4× 196 0.6× 113 0.5× 201 1.2× 35 1.9k
David C. Eustice United States 16 861 1.3× 195 0.6× 95 0.3× 90 0.4× 137 0.8× 22 1.3k

Countries citing papers authored by Shigeo Morimoto

Since Specialization
Citations

This map shows the geographic impact of Shigeo Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeo Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeo Morimoto more than expected).

Fields of papers citing papers by Shigeo Morimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeo Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeo Morimoto. The network helps show where Shigeo Morimoto may publish in the future.

Co-authorship network of co-authors of Shigeo Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeo Morimoto. A scholar is included among the top collaborators of Shigeo Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeo Morimoto. Shigeo Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawaguchiya, Mitsuyo, Noriko Urushibara, Meiji Soe Aung, et al.. (2018). Genetic diversity of pneumococcal surface protein A (PspA) in paediatric isolates of non-conjugate vaccine serotypes in Japan. Journal of Medical Microbiology. 67(8). 1130–1138. 13 indexed citations
2.
Aung, Meiji Soe, Mitsuyo Kawaguchiya, Noriko Urushibara, et al.. (2016). Molecular Characterization of Methicillin-Resistant Staphylococcus aureus from Outpatients in Northern Japan: Increasing Tendency of ST5/ST764 MRSA-IIa with Arginine Catabolic Mobile Element. Microbial Drug Resistance. 23(5). 616–625. 31 indexed citations
3.
4.
Sato, Hirotoshi, Shigeo Morimoto, & Tsutomu Hattori. (2012). A Thirty-Year Survey Reveals That Ecosystem Function of Fungi Predicts Phenology of Mushroom Fruiting. PLoS ONE. 7(11). e49777–e49777. 57 indexed citations
5.
Urakami, Tatsuhiko, et al.. (2007). Recent Change in the Annual Incidence of Childhood Type 2 Diabetes in the Tokyo Metropolitan Area. Clinical Pediatric Endocrinology. 16(2). 53–58. 4 indexed citations
6.
Urakami, Tatsuhiko, et al.. (2004). Optimal use of quick-acting insulin analogue in combination with basal insulin and its long-term effect in Japanese children and adolescents with type 1 diabetes. Diabetes Research and Clinical Practice. 68(2). 96–103. 1 indexed citations
7.
Matsumoto, Keita, et al.. (2004). Conformational Analysis of Tricyclic Ketolide TE-802 and Its Analogues. Heterocycles. 63(9). 2057–2057. 1 indexed citations
8.
Asaka, Toshifumi, Keiko Suzuki, Hiroyuki Sugiyama, et al.. (2003). Synthesis and Antibacterial Activity of a Novel Series of Acylides:  3-O-(3-Pyridyl)acetylerythromycin A Derivatives. Journal of Medicinal Chemistry. 46(13). 2706–2715. 47 indexed citations
9.
Urakami, Tatsuhiko, et al.. (2002). A Subtype of Markedly Abrupt Onset With Absolute Insulin Deficiency in Idiopathic Type 1 Diabetes in Japanese Children. Diabetes Care. 25(12). 2353–2354. 7 indexed citations
10.
Asaka, Toshifumi, et al.. (2001). Synthesis and Antibacterial Activity of the Tricyclic Ketolides TE-802 and Its Analogs.. The Journal of Antibiotics. 54(8). 664–678. 25 indexed citations
11.
Hara, Hiroshi, Saeko Uchida, Mari Aoki, et al.. (2000). Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1492(1). 31–44. 48 indexed citations
12.
Komurasaki, Toshi, Hitoshi Toyoda, Daisuke Uchida, & Shigeo Morimoto. (1997). Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tryosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene. 15(23). 2841–2848. 119 indexed citations
13.
Matsumoto, Keita, Akira Kawashima, Noriyoshi Sakai, et al.. (1995). Bassiatin, a New Platelet Aggregation Inhibitor Produced by Beauveria bassiana K-717. The Journal of Antibiotics. 48(12). 1407–1413. 44 indexed citations
14.
Morimoto, Shigeo, et al.. (1990). Chemical modification of erythromycins. VI. Structure and antibacterial activity of acid degradation products of 6-O-methylerythromycins A.. The Journal of Antibiotics. 43(5). 570–573. 16 indexed citations
15.
16.
Adachi, Takashi, et al.. (1989). Crystal and molecular structure of (14R)-14-hydroxy-6-O-methylerythromycin A.. The Journal of Antibiotics. 42(6). 1012–1014. 8 indexed citations
17.
Suwa, Toshio, Yoshiro Kohno, Hideo Yoshida, Shigeo Morimoto, & Tetsuya Suga. (1989). Uptake of O-Alkyl Erythromycin Derivatives in the Lung Tissue and Cells of Rats. Journal of Pharmaceutical Sciences. 78(9). 783–784. 3 indexed citations
18.
Adachi, Takashi, et al.. (1988). ISOLATION AND IDENTIFICATION OF METABOLITES OF TE-031 (A-56268) IN HUMAN URINE. 36(3). 264–273. 4 indexed citations
19.
Adachi, Takashi, et al.. (1988). 14-Hydroxy-6-O-methylerythromycins A, active metabolites of 6-O-methylerythromycin A in human.. The Journal of Antibiotics. 41(7). 966–975. 21 indexed citations
20.
Morimoto, Shigeo, Yōko Takahashi, Yoshiaki Watanabe, & SADAFUMI OMURA. (1984). Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A.. The Journal of Antibiotics. 37(2). 187–189. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuzuru Akamatsu Breakdown of academic impact, for papers by Sujata Sharma Breakdown of academic impact, for papers by Teck Kwang Lim Breakdown of academic impact, for papers by Nicola G. Wallis Breakdown of academic impact, for papers by Pei‐Lan He Breakdown of academic impact, for papers by K. Vosbeck Breakdown of academic impact, for papers by Sanjay Kumar Breakdown of academic impact, for papers by William E. Alborn Breakdown of academic impact, for papers by Ajith V. Kamath Breakdown of academic impact, for papers by David C. Eustice
Rankless by CCL
2026